Header Logo

Connection

Michael Gold to BRCA1 Protein

Back to Details
This is a "connection" page, showing publications Michael Gold has written about BRCA1 Protein.
Michael Gold
Connection Strength
0.060
BRCA1 Protein
  1. Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer. Ann Oncol. 2026 Apr; 37(4):503-520.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.